The New York Times reports a troubling story–benefits managers at some of the nation’s largest programs designed to keep Rx costs down have been running businesses on the side, with the net effect of dramatically increasing drug costs. Benefit Managers Profit by Specialty Drugs (subscription may be req’d) COMMENT: Just exactly who–or what–is supposed to [...]